Amelioration of nebivolol on renal interstitial fibrosis in UUO rats based on proteomic analysis
10.12092/j.issn.1009-2501.2022.07.002
- Author:
Lijun WU
1
;
Xin LI
1
;
Xinxin LI
1
;
Yan WANG
1
;
Lijuan CUI
2
Author Information
1. Department of Pharmacology, Shanxi Medical University
2. Functional Laboratory, Shanxi Medical University
- Publication Type:Journal Article
- Keywords:
nebivolol;
proteomics;
renal interstitial fibrosis;
unilateral ureteral obstruction
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(7):729-738
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To explore the effect and mechanism of nebivolol on renal interstitial fibrosis(RIF) in unilateral ureteral obstruction (UUO) model through TMT proteomics. METHODS: SD rats were divided into Sham group, UUO group, Neb group(UUO rats treated with nebivolol 10 mg·kg-1·d-1, i.g.). Left kidney was collected from rat on 7th, 14th and 21th day after modeling. HE staining was used to observe renal structure and Masson's staining was used to examine RIF. Proteomic and bioinformatics were conducted to screen and analysis the differential expressed proteins contrary regulated between UUO/Sham and Neb/UUO 21d after obstruction. Western blot were used to confirm protein expressions. RESULTS: Compared with Sham group, RIF in UUO rats aggravated gradually. Administration of nebivolol for 21 d ameliorated RIF in UUO rats. A total of 179 differential expressed proteins contrary regulated were identified shared between UUO/Sham and Neb/UUO groups. KEGG enrichment analysis and PPI showed that these differential expressed proteins were mainly involved in spliceosome pathway. Results of Western blot for Rbm8a, Srsf9 and Sart1 were in line with the results of proteomics. CONCLUSION: Spliceosome may play key role in the amelioration of nebivolol on RIF in UUO rats.
